[1] |
Álvarez Méndez A, Matía Almudévar P, Álvarez Hernández S. SARS-CoV2 bilateral pneumonia: chest X-ray evolution. Med Intensiva 2020;46:420-421.
|
[2] |
Hakim MS. SARS‐CoV‐2, Covid‐19, and the debunking of conspiracy theories. Reviews in medical virology 2021;31:e2222.
|
[3] |
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet 2020; 395:497-506.
|
[4] |
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet 2020;395:507-513.
|
[5] |
Haigh K, Syrimi ZJ, Irvine S, Blanchard TJ, Pervaiz MS, Toth AG, et al. Hyperinflammation with COVID-19: The key to patient deterioration? Clinical infection in practice 2020;7:100033.
|
[6] |
Eljilany I, Elzouki A-N. D-dimer, fibrinogen, and IL-6 in COVID-19 patients with suspected venous thromboembolism: a narrative review. Vascular health and risk management 2020:455-462.
|
[7] |
Landecho M, Yuste J, Gándara E, Sunsundegui P, Quiroga J, Alcaide A, et al. COVID‐19 retinal microangiopathy as an in vivo biomarker of systemic vascular disease? Journal of internal medicine 2021;289:116-120.
|
[8] |
Feng Z, Diao B, Wang R, Wang G, Wang C, Tan Y, et al. The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) directly decimates human spleens and lymph nodes. MedRxiv 2020:2020.03. 27.20045427.
|
[9] |
Xu X, Chang X, Pan H, Su H, Huang B, Yang M, et al. Pathological changes of the spleen in ten patients with coronavirus disease 2019 (COVID-19) by postmortem needle autopsy. Zhonghua bing li xue za zhi 2020;49:576-582.
|
[10] |
De Michele M, Kahan J, Berto I, Schiavo OG, Iacobucci M, Toni D, et al. Cerebrovascular complications of COVID-19 and COVID-19 vaccination. Circ Res 2022;130:1187-1203.
|
[11] |
Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, et al. A new coronavirus associated with human respiratory disease in China. Nature 2020;579:265-269.
|
[12] |
Xu X, Chang XN, Pan HX, Su H, Huang B, Yang M, et al. Pathological changes of the spleen in ten patients with coronavirus disease 2019 (COVID-19) by postmortem needle autopsy. Zhonghua bing li xue za zhi 2020;49:576-582.
|
[13] |
Lamb PM, Lund A, Kanagasabay RR, Martin A, Webb JAW, Reznek RH. Spleen size: how well do linear ultrasound measurements correlate with threedimensional CT volume assessments? Br J Radiol 2002;75:573-577.
|
[14] |
Elstein D, Hadas-Halpern I, Azuri Y, Abrahamov A, Bar-ziv Y, Zimran A. Accuracy of ultrasonography in assessing spleen and liver size in patients with Gaucher disease: comparison to computed tomographic measurements. J Ultrasound Med 1997;16:209-211.
|
[15] |
Tahtabasi M, Hosbul T, Karaman E, Akin Y, Konukoglu O, Sahiner F. Does COVID-19 cause an increase in spleen dimensions? Possible effects of immune activation, hematopoietic suppression and microthrombosis. Clinical imaging 2021;79:104-109.
|
[16] |
Haigh K, Syrimi ZJ, Irvine S, Blanchard TJ, Pervaiz MS, Toth AG, et al. Hyperinflammation with COVID-19: the key to patient deterioration? Clin Infect Pract 2020;7:100033.
|
[17] |
Tabatabaei SMH, Talari H, Moghaddas F, Rajebi H. CT features and Short-term prognosis of COVID-19 pneumonia: a single-center study from Kashan. Iran Radiol Cardiothorac Imaging 2020;2: e200130.
|
[18] |
SAMANCI C, ŞAYLAN B, YEŞİLDAL M, CAMURCUOGLU E, USTABAŞIOĞLU FE. Evaluation of spleen volume in thoracic computed tomography in patients with COVID-19 pneumonia. Anatolian Current Medical Journal 2021;3:93-97.
|